Induction of immune tolerance

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S399000, C548S338100, C544S331000

Reexamination Certificate

active

10719701

ABSTRACT:
Methods of inducing immune tolerance by administering an immunosuppressive agent and a compound represented by Formula (I) are disclosed:Additionally methods of suppressing an immune response by administering an immunosuppressive agent and a compound represented by Formula (I) are disclosed. Further disclosed are methods for treating autoimmune diseases by administering an immunosuppressive agent and a compound represented by Formula (I). The variables of Formula (I) are described herein.

REFERENCES:
patent: 5540931 (1996-07-01), Hewitt et al.
patent: 5654312 (1997-08-01), Andrulis, Jr. et al.
patent: 5795967 (1998-08-01), Aggarwal et al.
patent: 5801193 (1998-09-01), Ojo-Amaize et al.
patent: 5958413 (1999-09-01), Anagnostopulos et al.
patent: 5990103 (1999-11-01), Schonharting et al.
patent: 6020323 (2000-02-01), Cohen et al.
patent: 6030615 (2000-02-01), Bucala et al.
patent: 6204245 (2001-03-01), Siegel et al.
patent: 6211160 (2001-04-01), Wilson et al.
patent: 6235281 (2001-05-01), Stenzel et al.
patent: 6270766 (2001-08-01), Feldman et al.
patent: 6294170 (2001-09-01), Boone et al.
patent: 6299878 (2001-10-01), Pierpadi et al.
patent: 6306820 (2001-10-01), Bendele et al.
patent: 6331560 (2001-12-01), Shohami et al.
patent: 6337325 (2002-01-01), Schonharting et al.
patent: 6376665 (2002-04-01), Duan et al.
patent: 6420374 (2002-07-01), Bianco et al.
patent: 6432962 (2002-08-01), Horneman
patent: 6432968 (2002-08-01), Schonharting et al.
patent: 6503184 (2003-01-01), Ni et al.
patent: 6506569 (2003-01-01), Ni et al.
patent: 6509015 (2003-01-01), Salfeld et al.
patent: 2002/0119988 (2002-08-01), Sneddon et al.
patent: 0 401 747 (1990-12-01), None
patent: 0401747 (1990-06-01), None
patent: WO 94/08619 (1994-04-01), None
patent: WO 95/09652 (1995-04-01), None
patent: WO 98/39026 (1998-09-01), None
patent: WO-01/87849 (2001-05-01), None
patent: WO 01/87849 (2001-11-01), None
Hancock et al., Proc. Natl. Acad.Sci. vol. 93, pp. 13967-13972.
Yuan, X. et al., “A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection,”Transplantation 73(11):1736-1742 (2002).
Turner, D. M., et al., “A Genetic Marker of High TNF-α Production in Heart Transplant Recipients,”Transplantation, 60(10):1113-1117 (1995).
Couriel, D., et al., “THF-Alpha Inhibition for the Treatment of Chronic GVHD,”Blood, 10(11):847a (2002) Abstract.
Hancock, W. W., et al., “Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection,”Proc. Natl. Acad. Sci. USA93:13967-13972 (1996).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Induction of immune tolerance does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Induction of immune tolerance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Induction of immune tolerance will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3815374

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.